Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Subcutaneous Insulin Infusion (CSII) Versus Multiple Insulin Injections for Type 1 Diabetes Mellitus: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433120/all/Methotrexate_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed 28 March 2024.
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433120/all/Methotrexate_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed March 28, 2024.
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433120/all/Methotrexate_for_multiple_sclerosis_Edited__no_change_to_conclusions_
Continuous Subcutaneous Insulin Infusion (CSII) Versus Multiple Insulin Injections for Type 1 Diabetes Mellitus: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433120/all/Methotrexate_for_multiple_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
ID - 433120
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433120/all/Methotrexate_for_multiple_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -